| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-11 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-10 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-10 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.74 | 7e-08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.32 | 9e-08 |